Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DuPont Pharmaceuticals Co.

Division of Bristol-Myers Squibb Co.
www.dupont.com

Latest From DuPont Pharmaceuticals Co.

Bristol/Celgene A Record-Setting Merger, If It Happens

The mega-merger would be the third largest in biopharma history, but some analysts wonder if other suitors will try to acquire Bristol before the deal closes. Celgene’s partners, and their investors, are concerned about the ramifications.

Business Strategies M & A

Bristol/Celgene A Record-Setting Merger, If It Happens

The $74bn mega-merger would be the third largest in biopharma history, but some analysts wonder if other suitors will try to acquire Bristol before the deal closes.

Business Strategies M & A

Appointments: Astellas, MorphoSys, AZTherapies, Sigilon Therapeutics, Intec Pharma And Tenaya Therapeutics

This week's round-up includes promotions at Astellas, new CSOs at MorphoSys and Tenaya, a new president and CMO at AZTherapies, new directors at BioScience Managers, plus board changes at Intec and Sigilon.

Appointments BioPharmaceutical

APPOINTMENTS: Valeant, Gilead, Editas, Daiichi, Scancell, PhaseRx, Clintec, Acadia

This week’s announcements include Valeant’s appointment of an executive vice president finance, Editas Medicine’s appointment of a chief scientific officer, Clintec’s appointment of AstraZeneca’s former global research director and various board appointments by Acadia, Scancell, PhaseRx and Gilead.

Appointments BioPharmaceutical
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • DuPont Merck
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Bristol-Myers Squibb Co.
  • Senior Management
  • Richard U De Shutter, Chmn. & CEO
    Gary M Pfeiffer, SVP, CFO
    Timothy R Wright, SVP, Strategy & Corp. Bus. Dev.
    Richard Goodmanson, EVP, COO
  • Contact Info
  • DuPont Pharmaceuticals Co.
    Phone: (302) 992-5000
    Chestnut Run Plaza
    974 Centre Rd.
    P.O. Box 80722 Wilmington, DE 19880
    USA
UsernamePublicRestriction

Register